Faes Farma, S.A. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | €3.58 |
| 52週高値 | €3.83 |
| 52週安値 | €2.91 |
| ベータ | 0.52 |
| 11ヶ月の変化 | -2.98% |
| 3ヶ月変化 | 3.17% |
| 1年変化 | 18.94% |
| 33年間の変化 | 3.59% |
| 5年間の変化 | -28.11% |
| IPOからの変化 | 253.09% |
最新ニュース
Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 03
Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think
Mar 01Recent updates
Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 03Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think
Mar 01Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316
Dec 18Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316
Dec 04Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?
Nov 24Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly
May 03Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?
Sep 21Is Faes Farma (BME:FAE) A Risky Investment?
Aug 03Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth
Jun 17Is Faes Farma (BME:FAE) Using Too Much Debt?
Mar 27Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14
Dec 13Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17
Nov 29Is Faes Farma (BME:FAE) A Risky Investment?
Sep 21Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year
Jul 31Is Faes Farma (BME:FAE) Using Too Much Debt?
May 01Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)
Apr 07Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?
Mar 22Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations
Mar 06Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment
Feb 22I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease
Jan 16Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly
Dec 08株主還元
| FAE | ES Pharmaceuticals | ES 市場 | |
|---|---|---|---|
| 7D | -0.8% | -2.0% | -0.6% |
| 1Y | 18.9% | 11.6% | 25.9% |
業界別リターン: FAE exceeded the Spanish Pharmaceuticals industry which returned 11.6% over the past year.
リターン対市場: FAE underperformed the Spanish Market which returned 25.9% over the past year.
価格変動
| FAE volatility | |
|---|---|
| FAE Average Weekly Movement | 2.0% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 2.9% |
| 10% most volatile stocks in ES Market | 5.2% |
| 10% least volatile stocks in ES Market | 0.6% |
安定した株価: FAE has not had significant price volatility in the past 3 months compared to the Spanish market.
時間の経過による変動: FAE's weekly volatility (2%) has been stable over the past year.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1933 | 1,762 | n/a | faesfarma.com |
ファエス・ファルマ社（Faes Farma, S.A.）は、医薬品、ヘルスケア製品、原材料の研究、開発、生産、販売を世界中で行っている。医薬品・ヘルスケア製品事業、動物栄養・健康事業、医薬品原料事業を展開。様々な治療分野向けの製品を提供している。また、動物栄養・健康製品も提供している。ファエス・ファルマ社は1933年に設立され、スペインのレイオアに本社を置く。
Faes Farma, S.A. 基礎のまとめ
| FAE 基礎統計学 | |
|---|---|
| 時価総額 | €1.11b |
| 収益（TTM） | €97.59m |
| 売上高(TTM) | €504.04m |
11.4x
PER（株価収益率2.2x
P/SレシオFAE は割高か？
公正価値と評価分析を参照収益と収入
| FAE 損益計算書（TTM） | |
|---|---|
| 収益 | €504.04m |
| 売上原価 | €169.88m |
| 売上総利益 | €334.16m |
| その他の費用 | €236.57m |
| 収益 | €97.59m |
直近の収益報告
Sep 30, 2024
次回決算日
該当なし
| 一株当たり利益（EPS） | 0.31 |
| グロス・マージン | 66.30% |
| 純利益率 | 19.36% |
| 有利子負債／自己資本比率 | 6.9% |
FAE の長期的なパフォーマンスは？
過去の実績と比較を見る